EYPT FY 2016 Earnings — EyePoint Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

EYPTEyePoint Pharmaceuticals, Inc.

$1B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-93.9% YoY

Gross Profit

$805,00049.7% margin

Operating Income

-$22M-1344.1% margin

Net Income

-$22M-1330.1% margin

EPS (Diluted)

$-6.81

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$16M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$32M

Total Liabilities

$11M

Stockholders' Equity

$21M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$27M	-93.9%
Gross Profit	$805,000	$12M	-93.4%
Operating Income	-$22M	$6M	-439.1%
Net Income	-$22M	$6M	-439.5%